Protease-activated quantum dot probes.

We have developed a novel nanoparticulate luminescent probe with inherent signal amplification upon interaction with a targeted proteolytic enzyme. This construct may be useful for imaging in cancer detection and diagnosis. In this system, quantum dots (QDs) are bound to gold nanoparticles (AuNPs) via a proteolytically degradable peptide sequence to non-radiatively suppress luminescence. A 71% reduction in luminescence was achieved with conjugation of AuNPs to QDs. Release of AuNPs by peptide cleavage restores radiative QD photoluminescence. Initial studies observed a 52% rise in luminescence over 47 h of exposure to 0.2 mg/mL collagenase. These probes can be customized for targeted degradation simply by changing the sequence of the peptide linker.

[1]  R. Ball,et al.  Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues , 2005, British Journal of Cancer.

[2]  Christopher M. Overall,et al.  In search of partners: linking extracellular proteases to substrates , 2007, Nature Reviews Molecular Cell Biology.

[3]  Roger Y. Tsien,et al.  Creating new fluorescent probes for cell biology , 2003, Nature Reviews Molecular Cell Biology.

[4]  H. Mori,et al.  Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.

[5]  Dustin J Maly,et al.  Peptide microarrays for the determination of protease substrate specificity. , 2002, Journal of the American Chemical Society.

[6]  Michel Eichelbaum,et al.  Pharmacogenomics and individualized drug therapy. , 2006, Annual review of medicine.

[7]  N. Bianchi,et al.  Mitochondrial genome instability in human cancers. , 2001, Mutation research.

[8]  A. Alivisatos Semiconductor Clusters, Nanocrystals, and Quantum Dots , 1996, Science.

[9]  Igor L. Medintz,et al.  Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. , 2003, Journal of the American Chemical Society.

[10]  G. M. Liuzzi,et al.  Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies. , 2007, Trends in molecular medicine.

[11]  B. Turk Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[12]  N. Hooper Proteases in Biology And Medicine , 2002 .

[13]  John Calvin Reed Mechanisms of apoptosis avoidance in cancer. , 1999, Current opinion in oncology.

[14]  A. Marcus,et al.  Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.

[15]  Shuming Nie,et al.  Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.

[16]  Sherry L. Niessen,et al.  Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.

[17]  E. Cera,et al.  A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases , 2000, Protein science : a publication of the Protein Society.

[18]  Th. Förster Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .

[19]  Ralph Weissleder,et al.  A dual fluorochrome probe for imaging proteases. , 2004, Bioconjugate chemistry.

[20]  J. Matthew Mauro,et al.  Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein , 2000 .

[21]  H. Mattoussi,et al.  Use of quantum dots for live cell imaging , 2004, Nature Methods.

[22]  David C. Lee,et al.  An essential role for ectodomain shedding in mammalian development. , 1998, Science.

[23]  C. Martínez-A,et al.  The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells* , 1999, The Journal of Biological Chemistry.

[24]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[25]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[26]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[27]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[28]  D. Ratkowsky,et al.  A suitable parameterization of the Michaelis-Menten enzyme reaction. , 1986, The Biochemical journal.

[29]  Ralph Weissleder,et al.  Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.

[30]  W. Webb,et al.  Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo , 2003, Science.

[31]  Detection of Mitochondrial Caspase Activity in Real Time In Situ in Live Cells , 2004, Microscopy and Microanalysis.

[32]  J. Post,et al.  Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.

[33]  Albert Libchaber,et al.  Single-molecule measurements of gold-quenched quantum dots. , 2004, Physical review letters.

[34]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[35]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[36]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[37]  T. Nann,et al.  Single Quantum Dots in Silica Spheres by Microemulsion Synthesis , 2005 .

[38]  X. Puente,et al.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.

[39]  Igor L. Medintz,et al.  Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates , 2006, Nature materials.

[40]  Igor L. Medintz,et al.  Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. , 2006, Bioconjugate chemistry.

[41]  Xiaogang Peng,et al.  Experimental Determination of the Extinction Coefficient of CdTe, CdSe, and CdS Nanocrystals , 2003 .

[42]  B. Sheu,et al.  A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.

[43]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[44]  K. McCoy,et al.  New assay using fluorogenic substrates and immunofluorescence staining to measure cysteine cathepsin activity in live cell subpopulations , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[45]  H. Kita,et al.  The role of protease activation of inflammation in allergic respiratory diseases. , 2004, The Journal of allergy and clinical immunology.

[46]  Joachim O. Rädler,et al.  Hydrophobic Nanocrystals Coated with an Amphiphilic Polymer Shell: A General Route to Water Soluble Nanocrystals , 2004 .

[47]  D. Farley,et al.  Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity. , 2003, Assay and drug development technologies.

[48]  R. Weinshilboum Inheritance and drug response. , 2003, The New England journal of medicine.

[49]  J. Matthew Mauro,et al.  Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.

[50]  Emanuel F. Petricoin,et al.  Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.

[51]  W. Redd Behavioral intervention for cancer treatment side effects. , 1994, Acta oncologica.

[52]  Igor L. Medintz,et al.  Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.

[53]  Zhenyu Ding,et al.  Predicting Cancer Drug Response by Proteomic Profiling , 2006, Clinical Cancer Research.

[54]  J. West,et al.  Cell migration through defined, synthetic extracellular matrix analogues , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Bonnie F. Sloane,et al.  Lysosomal cathepsin B: correlation with metastatic potential. , 1981, Science.

[56]  B. Krauskopf,et al.  Proc of SPIE , 2003 .

[57]  Zeev Rosenzweig,et al.  Synthesis and application of quantum dots FRET-based protease sensors. , 2006, Journal of the American Chemical Society.

[58]  Ralph Weissleder,et al.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.

[59]  F. Luciani,et al.  A mathematical model of protein degradation by the proteasome. , 2005, Biophysical journal.

[60]  Shinsuke Sando,et al.  A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.

[61]  N. Rosenzweig,et al.  Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors. , 2007, Analytical chemistry.

[62]  Peter Friedl,et al.  Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.

[63]  Isabelle Richard,et al.  Imaging calpain protease activity by multiphoton FRET in living mice. , 2005, Journal of molecular biology.

[64]  Matthew B. Johnson,et al.  Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. , 2003, Journal of the American Chemical Society.

[65]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[66]  Byron Ballou,et al.  Noninvasive imaging of quantum dots in mice. , 2004, Bioconjugate chemistry.

[67]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[68]  Jingsong Xu,et al.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.

[69]  Daniele Gerion,et al.  Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and , 2004 .

[70]  H. Verspaget,et al.  Proteases as prognostic markers in cancer , 1998, BMJ.

[71]  F. Blasi,et al.  In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion , 1991, The Journal of cell biology.

[72]  M. Lavin,et al.  A sensitive fluorescent assay for measuring the cysteine protease activity of Der p 1, a major allergen from the dust mite Dermatophagoides pteronyssinus. , 1998, Molecular pathology : MP.

[73]  R. Weissleder A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[74]  D. Reinhoudt,et al.  Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects. , 2002, Physical review letters.

[75]  Matthew D Disney,et al.  Hybridization-based unquenching of DNA hairpins on au surfaces: prototypical "molecular beacon" biosensors. , 2003, Journal of the American Chemical Society.

[76]  M. Stack,et al.  Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide. , 1989, The Journal of biological chemistry.

[77]  M. Kris,et al.  Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  W. Wiczk,et al.  Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B. , 2004, Acta biochimica Polonica.

[79]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[80]  R. Paridaens,et al.  Proteases and metastasis: clinical relevance nowadays? , 2005, Current opinion in oncology.

[81]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[82]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  W. Birchmeier,et al.  Epithelial-mesenchymal transitions in cancer progression. , 1996, Acta anatomica.

[84]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[85]  J. Kos,et al.  Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.

[86]  K. Nabeshima,et al.  Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.

[87]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[88]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[89]  A. Libchaber,et al.  Single-mismatch detection using gold-quenched fluorescent oligonucleotides , 2001, Nature Biotechnology.

[90]  Kenji Yamamoto,et al.  Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. , 2003, Biochemical and biophysical research communications.

[91]  M. Tatham,et al.  A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing. , 2007, Analytical biochemistry.

[92]  Jiqiu Chen,et al.  Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction , 2005, Circulation.

[93]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[94]  Rüdiger Rudolf,et al.  Looking forward to seeing calcium , 2003, Nature Reviews Molecular Cell Biology.

[95]  G. Ginsburg,et al.  The path to personalized medicine. , 2002, Current opinion in chemical biology.

[96]  Ralph Weissleder,et al.  Developing a peptide-based near-infrared molecular probe for protease sensing. , 2004, Bioconjugate chemistry.

[97]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[98]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[99]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[100]  Bonnie F. Sloane,et al.  Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment , 2007, Molecular Cancer Research.

[101]  M. Ozkan,et al.  Nano-oncology: drug delivery, imaging, and sensing , 2006, Analytical and bioanalytical chemistry.

[102]  S. Chevret,et al.  Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. , 2001, The Journal of investigative dermatology.

[103]  Nasreen S Jessani,et al.  Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[105]  S. L. Bridges The genetics of rheumatoid arthritis: Influences on susceptibility, severity, and treatment response , 1999, Current rheumatology reports.

[106]  Gilbert S. Omenn,et al.  Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project , 2004, Disease markers.

[107]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[108]  Sangeeta N. Bhatia,et al.  Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking , 2004 .

[109]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[110]  G. Giannelli,et al.  Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.

[111]  Jeffrey A. Hubbell,et al.  Polymeric biomaterials with degradation sites for proteases involved in cell migration , 1999 .

[112]  C. Larabell,et al.  Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.

[113]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[114]  Min Zhou,et al.  Quantum dots and peptides: a bright future together. , 2007, Biopolymers.